These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3045361)

  • 1. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
    Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N
    Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C; Mantellini R; Fanti P; Sciarra F
    Minerva Med; 1983 Apr; 74(14-15):791-7. PubMed ID: 6339999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
    Angeli P; Dalla Pria M; De Bei E; Albino G; Caregaro L; Merkel C; Ceolotto G; Gatta A
    Hepatology; 1994 Jan; 19(1):72-9. PubMed ID: 8276370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
    Opocher G; Armanini D; Fallo F; Mantero F
    Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390
    [No Abstract]   [Full Text] [Related]  

  • 6. Adaptation to chronic potassium loading in normal man.
    Hené RJ; Koomans HA; Boer P; Dorhout Mees EJ
    Miner Electrolyte Metab; 1986; 12(3):165-72. PubMed ID: 3523191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M; Cuppone R; Ricci GL
    Arzneimittelforschung; 1988 Oct; 38(10):1492-5. PubMed ID: 3058132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronobiological study of factors affecting plasma aldosterone concentration in cirrhosis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Capani F; Baraldini M; Gasbarrini G
    Gastroenterology; 1986 Sep; 91(3):683-91. PubMed ID: 3525316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium excretion and sodium-free volume expansion in dogs: effect of inhibition of aldosterone activity by canrenoate.
    Bie P
    Acta Physiol Scand; 1976 Oct; 98(2):272-4. PubMed ID: 983738
    [No Abstract]   [Full Text] [Related]  

  • 10. Single-dose i.v. Aldactone for congestive heart failure: a preliminary observation.
    Ceremuzyński L; Budaj A; Michorowski B
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):417-21. PubMed ID: 6629545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of Na supplement and limitation on blood PRA, AII, ALD and renal function in patients with liver cirrhosis].
    Gu XB; Chen HK; Zhu YF; Pei H; Liu XY
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):370. PubMed ID: 15225438
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of canrenoate potassium given orally in ascitogenic cirrhosis].
    Sarti F; Milandri GL; Piemontese A; Macchia S; Simoni S; Dal Monte PR
    Minerva Dietol Gastroenterol; 1984; 30(3):273-80. PubMed ID: 6504377
    [No Abstract]   [Full Text] [Related]  

  • 13. [Determination of plasma renin activity in edematous cirrhosis. Influence of various depletive treatments].
    Cottin S; Miniconi P; Belet JL; Cadudal JL; Talmant JC; Bailleux A
    Sem Hop; 1973 Apr; 49(19):1357-63. PubMed ID: 4355382
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis.
    Bernardi M; De Palma R; Trevisani F; Santini C; Servadei D; Gasbarrini G
    Z Kardiol; 1985; 74 Suppl 2():129-34. PubMed ID: 3890391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.
    Hiramatsu K; Yamada T; Yukimura Y; Komiya I; Ichikawa K; Ishihara M; Nagata H; Izumiyama T
    Arch Intern Med; 1981 Nov; 141(12):1589-93. PubMed ID: 7030245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The regulation of plasma aldosterone in hemodialysis patients].
    Louis F; Zwahlen A; Favre H; Vallotton M
    Schweiz Med Wochenschr; 1980 Dec; 110(49):1882-4. PubMed ID: 7006078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidural analgesia inhibits the renin and aldosterone response to surgery.
    Brandt MR; Olgaard K; Kehlet H
    Acta Anaesthesiol Scand; 1979 Jun; 23(3):267-72. PubMed ID: 484183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC; Bräuninger HJ
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurohumoral activity in liver cirrhosis].
    Lazúrová I; Rosochová I; Lichardus B; Trejbal D; Hildebrand T; Tkác I; Machánová Y; Murár J
    Vnitr Lek; 1995 Oct; 41(10):667-71. PubMed ID: 8578696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.